Keyword: marketing

News

FDA Panel Votes to Relax Avandia Restrictions

07.06.2013 - U.S. health advisers voted on Thursday to recommend relaxing market restrictions on GlaxoSmithKline's diabetes drug Avandia, the former blockbuster at the center of one of the...

News

Bausch & Lomb's Ista Pleads Guilty Over Kickbacks

25.05.2013 - Ista Pharmaceuticals pleaded guilty on Friday to charges it used kickbacks and improper marketing to boost sales of a drug meant to treat eye pain and agreed to pay $33.5 million...

News

Malvern Instruments, Netzsch Sign Agreement to Cooperate

29.04.2013 - Materials and biophysical characterization company Malvern Instruments and Netzsch Grinding & Dispersing (headquartered in Selb, Germany), a worldwide manufacturer of industrial...

News

U.S. Sues Novartis, Alleging Kickbacks to Pharmacies

24.04.2013 - The U.S. government filed a civil fraud lawsuit against Novartis on Tuesday, accusing a unit of the Swiss drug maker of causing the Medicare and Medicaid programs to pay tens of...

News

Nickel Institute Appoints Nigel Ward as Director for Promotion & Market Development

09.04.2013 - The Nickel Institute is pleased to announce the appointment of Nigel Ward as Director for Promotion & Market Development. In this role, Nigel is responsible for raising awareness...

News

Par to Pay $45 Million, End US Probes Over AIDS Appetite Drug

05.03.2013 - Par Pharmaceutical has agreed to pay $45 million to settle federal criminal and civil probes over its marketing and sale of a drug to treat appetite loss in AIDS patients, a...

News

Arkema, NatureWorks Launch Marketing Collaboration

08.01.2013 - Altuglas International, a subsidiary of Arkema, with its Plexiglas and Altuglas acrylic resins (Americas and Rest of World, respectively) and NatureWorks, a leader in the bio...

News

U.S. Court Approves Amgen's $762 Million Payment in Drug Case

20.12.2012 - A federal judge on Wednesday approved a $762 million payment from Amgen, the final step to resolve nearly a dozen criminal and civil cases stemming from the sale of its once...